Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Dwertmann Rico

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Plos One|January 24, 2025
Correction: High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Plos One|July 21, 2022
High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
BMC Cancer|July 3, 2024
KLK7 expression in human tumors: a tissue microarray study on 13,447 tumorsSimon Kind, Carolina Palacios Castillo, Ria Schlichter, et al.
Pathology Oncology Research : POR|July 18, 2020
Secreted Frizzled-Related Protein 4 (SFRP4) Is an Independent Prognostic Marker in Prostate Cancers Lacking TMPRSS2: ERG FusionsChristian Bernreuther, Ferdous Daghigh, Katharina Möller, et al.
Molecular Medicine (Cambridge, Mass.)|June 29, 2026
Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor typesNatalia Gorbokon, Katharina Teljuk, Nina Schraps, et al.
The American Journal of Surgical Pathology|January 25, 2024
GAD2 Is a Highly Specific Marker for Neuroendocrine Neoplasms of the PancreasMaximilian Lennartz, Nick Benjamin Dünnebier, Doris Höflmayer, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|May 17, 2024
Staining pattern of specific and cross-reacting Melan-A antibodies: A comparative study on 15,840 samples from 133 human tumor typesShiva Boroojerdi, Sören Weidemann, Anne Menz, et al.
The American Journal of Surgical Pathology|August 12, 2024
Prevalence of S-methyl-5'-thioadenosine Phosphorylase (MTAP) Deficiency in Human Cancer: A Tissue Microarray Study on 13,067 Tumors From 149 Different Tumor TypesNatalia Gorbokon, Niklas Wößner, Maximilian Lennartz, et al.
Diagnostics (Basel, Switzerland)|August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor PhenotypeViktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
Plos One|January 24, 2025
Correction: High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Cancer Biomarkers : Section a of Disease Markers|January 23, 2023
PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samplesKatharina Möller, Madeleine Knöll, Elena Bady, et al.
Plos One|July 21, 2022
High prevalence of p16 staining in malignant tumorsNoémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
Pageof 4